相关实验视频
Updated: Jan 10, 2026

06:07
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
963
ATPase抑制因子1驱动线粒体能量代谢重编程以通过ESR1/miR-20a-3p/GNAZ通路促进HCC血管性仿真
Shilun Wu1, Changyu Yao1, Lu Fang2,3
1Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing 100043, China.
Research (Washington, D.C.)
|November 27, 2025
概括
ATPase抑制因子1 (IF1) 通过增强血管仿真 (VM) 来促进肝细胞癌 (HCC) 转移. IF1调节ESR1/miR-20a-3p/GNAZ轴,为HCC提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 血管仿真 (VM) 是肝细胞癌 (HCC) 转移的一个关键因素.
- 识别VM的新型调节剂对于开发有效的HCC疗法至关重要.
研究的目的:
- 鉴定和描述ATPase抑制因子1 (IF1) 在HCC血管性模仿和转移中的作用.
- 阐明IF1介导的VM形成背后的分子机制.
主要方法:
- 利用GeneCard和癌症基因组图谱数据库来识别潜在的监管者.
- 进行了体外细胞培养和体内动物实验,以评估IF1的功能.
- 利用转录组测序,双露西法酶记者测定和分子分析来发现信号通路.
主要成果:
- IF1被确定为HCC细胞管形成,VM和肺转移的促进者.
- IF1的淘汰导致miR-20a-3p的表达升高,从而逆转了IF1诱导的VM.
- 在HCVVM和转移中发现了一种涉及IF1,ESR1,miR-20a-3p和GNAZ的新途径.
结论:
- IF1通过新的IF1/ESR1/miR-20a-3p/GNAZ轴促进HCCVM和转移.
- 这个轴涉及线粒体的代谢重编程,反应性氧物种的积累和ESR1.1的表观遗传调节.
- 鉴定的途径为抑制HCC进展提供了潜在的治疗点.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
ATP Synthase: Mechanism
16.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.6K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Energy to Drive Translocation
2.6K
Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Generally, polypeptides are unfolded by two distinct...
2.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K

